Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihyper- tensive treatment and development of heart failure in hyperten- sion: a bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med. 2011;171:384 394. doi: 10.1001/archinternmed.2010.427. 32. Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison Him- melfarb CR. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the mi- nority view. Ann Intern Med. 2014;160:499 503. doi: 10.7326/ M13-2981. 33. Borden WB, Maddox TM, Tang F, Rumsfeld JS, Oetgen WJ, Mullen JB, Spinler SA, Peterson ED, Masoudi FA. Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014;64:2196 2203. doi: 10.1016/j.jacc.2014.09.022. 34. Rosendorff C. Blood pressure targets: still struggling for the right answer. J Am Coll Cardiol. 2014;64:2204 2206. doi: 10.1016/j. jacc.2014.07.994. 35. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis [published correction appears in Lancet. 2002;359:360]. Lancet. 2001;358:1305 1315. doi: 10.1016/S0140-6736(01)06411-X. 36. Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collabora- tive Research Group. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Pre- vent Heart Attack Trial. Circulation. 2006;113:2201 2210. doi: 10.1161/CIRCULATIONAHA.105.544031. 37. Yusuf S. Preventing vascular events due to elevated blood pressure. Circulation. 2006;113:2166 2168. doi: 10.1161/ CIRCULATIONAHA.106.620757. 38. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. 